Famotidine 20 mg Tablets — Generic For Pepcid — Dr Reddy

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Famotidine tablets are a histamine-2 (H2) receptor antagonist taken by mouth. They are indicated in adult and pediatric patients 40 kg and greater for active duodenal ulcer, active gastric ulcer, symptomatic nonerosive GERD, and erosive esophagitis due to GERD diagnosed by biopsy.

In adults, famotidine tablets are also indicated for pathological hypersecretory conditions, such as Zollinger-Ellison syndrome and multiple endocrine neoplasias, and for reducing the risk of duodenal ulcer recurrence.

The tablets may be taken once daily before bedtime or twice daily in the morning and before bedtime, with or without food. The label also notes that famotidine may be given with antacids.

Common side effects reported in trials include headache, dizziness, constipation, and diarrhea. The label also warns about possible CNS effects, especially in elderly patients and patients with renal impairment.

Storage Information

STORAGE AND HANDLING Famotidine tablets USP, 20 mg are yellow, film-coated, round shaped tablets with ‘C’ 119 on one side and plain on other side and are supplied in bottles of 30’s, 100’s and 1,000’s counts. Storage Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Dispense in a USP tight, light-resistant container.

Key Counseling Points

• Famotidine is taken by mouth and may be taken with or without food.
• The label says it can be taken once daily before bedtime or twice daily in the morning and before bedtime, as recommended.
• Famotidine may be given with antacids.
• Common adverse reactions listed in the label include headache, dizziness, constipation, and diarrhea.
• Tell the pharmacist or prescriber about a history of serious allergy to famotidine or other H2 receptor antagonists.
• The label warns that elderly patients and patients with renal impairment may be at higher risk for CNS adverse reactions.
• The label notes that symptom relief does not rule out gastric malignancy in adults; follow-up evaluation may be needed if response is poor or symptoms return early.
• Famotidine can reduce absorption of some other medicines, and the label says some interacting drugs are not recommended with famotidine.
• The label says to reduce the dosage in moderate to severe renal impairment.
• For pediatric patients weighing less than 40 kg, the 20 mg and 40 mg tablet strengths are not recommended.

Helpful Patient Education

Famotidine tablets are a prescription H2 receptor antagonist used for several acid-related conditions, including duodenal ulcer, gastric ulcer, GERD, erosive esophagitis due to GERD, and certain hypersecretory conditions in adults. The tablet is available in 20 mg and 40 mg strengths, and the label includes dosing guidance for adults and pediatric patients 40 kg and greater.

This product page provides educational information based on the DailyMed label, including uses, general administration directions, common adverse reactions, and key safety warnings such as renal dosing considerations and possible drug interactions.

Medication Summary last generated: 2026-07-18 02:39:59